News

The new Cochlear™ Nucleus® Nexa™ System is the first and only hearing implant featuring internal memory and upgradeable ...
Macquarie has released a new note on Cochlear Ltd (ASX: COH) shares following the company's FY25 profit guidance change.
Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The content is current as ...
Cochlear could be an ASX share to buy and hold for growth investors. It is the global leader in implantable hearing solutions ...
Mayne Pharma (ASX:MYX) shareholders have overwhelmingly approved the company’s $600 million takeover scheme of arrangement, ...
UBS has upgraded its rating on hearing implant company Cochlear, expecting new product releases to support ...